Inhibition of growth of MOPC 104E cells in immunosuppressed mice.
In this report we provide evidence that suggests that MOPC 104E may come under regulation in highly immunosuppressed hosts depleted of T cells. Mice that are adult thymectomized, total body irradiated, and transplanted with bone marrow cells were able to resist the growth of MOPC 104E cells. Spleen cells from such animals had low NK activity and no cytotoxicity against MOPC 104E, and poor response to Con A, PHA, and LPS. The animals were deficient in Lyt-1+ and Lyt-2+ cells. The growth of MOPC 104E cells was measured by using the circulating level of MOPC 104E IgM in vivo in mice treated by different modalities. We observed that inhibition of tumor growth in vivo varied with the treatment of the host. Growth was inhibited in the host in the following order: ATXBM greater than XBM greater than NORMAL greater than ATx mice.
D000818:Animals; D000950:Antigens, Ly; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000276:immunology* / Q000473:pathology / Q000528:radiation effects; D003602:Cytotoxicity, Immunologic / Q000528:radiation effects; D005260:Female; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation / Q000528:radiation effects; D051379:Mice; D008807:Mice, Inbred BALB C; D009194:Myeloma Proteins; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000276:immunology; D010954:Plasmacytoma / Q000276:immunology* / Q000473:pathology; D011828:Radiation Chimera; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000145:classification
D000950:Antigens, Ly; D009194:Myeloma Proteins